Evidence and clinical judgment*: Treatment of cerebral vein thrombosis

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1109-1115

  Ageno, Walter ^a   Dentali, Francesco ^a   Squizzato, Alessandro ^a   Baglin, Trevor ^b   Douketis, James ^c   Lansberg, Martin ^d   Paciaroni, Maurizio ^e   Palareti, Gualtiero ^f  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN VEIN; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; ITALY; LUNG EMBOLISM; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; VEIN THROMBOSIS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; HEALTH CARE PLANNING; INTRACRANIAL THROMBOSIS; PATHOLOGY;

CEREBRAL VEINS; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HEPARIN; INTRACRANIAL THROMBOSIS; ITALY; PRACTICE GUIDELINES AS TOPIC; THROMBOLYTIC THERAPY;

EID: 77953148473     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-12-0827     Document Type: Article

References (14)

1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352:1791-1798.
2. Bousser MG, Ferro JM. Cerebral venous thrombosis; an update. Lancet Neurol 2007; 6: 162-170.
3. Van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005; 65: 192-196.
4. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
5. Albers GW, Amarenco P, Easton JD, et al.; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 630S-669S.
6. Sacco RL, Adams R, Albers G, et al; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Circulation 2006; 113: e409-449.
7. th, 2009.
8. th, 2009.
9. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
10. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-488. (Pubitemid 29115380)
11. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002; 4: CD002005.
12. Ciccone A, Canhão P, Falcão F, et al. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004; 1: CD003693.
13. Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003; 15: 159-166.
14. Dentali F, Gianni M, Crowther MA, et al. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108: 1129-1134.